Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck
Rachel Carter, Mateus Milani, Michael Bruce Butterworth, Ahoud Alotibi et autres
Abstract Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common cancer worldwide, with overall survival of less than 50%. Current therapeutic strategies involving a combination of surgery, radiation, and/or chemotherapy are associated with debilitating side effects, highlighting …
gb (code pays fourni par la source)